Open AccessSignificant benefits of osimertinib in treating acquired resistance to first-generation EGFR-TKIs in lung squamous cell cancer: A case report
Author(s) -
Yan Zhang,
Huimin Chen,
Yongmei Liu,
Feng Peng,
Min Yu,
Wei-Ya Wang,
Heng Xu,
Yongsheng Wang,
You Lü
Publication year - 2019
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v7.i10.1221
Subject(s) - osimertinib , t790m , medicine , gefitinib , lung cancer , erlotinib , resistance mutation , oncology , epidermal growth factor receptor , cancer research , mutation , cancer , biology , gene , polymerase chain reaction , genetics , reverse transcriptase